Where was keytruda developed?

Keytruda (pembrolizumab) was developed by the U.S. biotechnology company Merck (known as Merck Sharp & Dohme, a division of Merck & Co.). It is an antibody drug that came from Merck’s internal research and development program for immuno-oncology therapies.